上半年20起大型药企与中国创新药公司交易!

创鉴汇
16 Jul

2025年上半年,大型药企与中国创新药公司之间的交易活动活跃度提高,反映出中国在全球创新药领域的快速崛起和强大吸引力。根据创鉴汇不完全统计,上半年中国创新药企与大型药企共达成20笔交易,披露的交易潜在总金额近300亿美元,其中单笔最高达60.5亿美元,显示出大型药企对中国创新药的高度信心。全球创新药市场正经历高速增长,中国凭借其在生物技术平台(如双特异性抗体、AI驱动研发)的独特优势,成为跨国药企...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10